Auna (NYSE:AUNA) Upgraded to Strong-Buy at Wall Street Zen

Wall Street Zen upgraded shares of Auna (NYSE:AUNA – Free Report) from a buy rating to a strong-buy rating in a research note released on Saturday,Wall Street Zen reports.

Separately, Weiss Ratings reissued a “sell (d)” rating on shares of Auna in a report on Monday, September 21st. One investment analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating, two have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $6.97.

Read Our Latest Stock Analysis on Auna

Auna Trading Up 2.5%

NYSE:AUNA opened at $5.16 on Friday. The stock has a 50-day simple moving average of $5.21 and a 200-day simple moving average of $5.12. The stock has a market cap of $381.52 million, a P/E ratio of 73.65 and a beta of 0.62. Auna has a 1 year low of $4.09 and a 1 year high of $6.30. The company has a debt-to-equity ratio of 1.61, a quick ratio of 1.00 and a current ratio of 1.08.

Auna (NYSE:AUNA – Get Free Report) last released its quarterly earnings data on Friday, August 14th. The company reported $0.15 EPS for the quarter, missing analysts’ consensus estimates of $0.26 by ($0.11). The business had revenue of $362.85 million during the quarter, compared to analysts’ expectations of $357.39 million. Auna had a net margin of 0.44% and a return on equity of 12.88%. As a group, analysts anticipate that Auna will post 0.79 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently modified their holdings of AUNA. Renaissance Technologies LLC raised its position in Auna by 487.7% during the 1st quarter. Renaissance Technologies LLC now owns 668,457 shares of the company’s stock worth $3,683,000 after buying an additional 554,707 shares during the last quarter. Lazard Asset Management LLC purchased a new position in Auna in the first quarter valued at about $557,000. Hsbc Holdings PLC purchased a new position in Auna in the first quarter valued at about $324,000. Arrowstreet Capital Limited Partnership purchased a new position in Auna in the first quarter valued at about $316,000. Finally, Squarepoint Ops LLC acquired a new stake in shares of Auna during the 2nd quarter valued at approximately $149,000.

Auna News Summary

Here are the key news stories impacting Auna this week:

  • Positive Sentiment: Auna reaffirmed its full-year 2026 revenue-growth guidance, supported by favorable third-quarter patient volumes and specialty-service trends. The company also cited signs of recovery in Mexico, which may help offset pressure elsewhere. Auna Announces Preliminary Update to Full-Year 2026 Outlook
  • Positive Sentiment: The company said all conditions precedent have been fulfilled for construction of the Centro Ambulatorio Trecca in Peru under its public-private partnership with EsSalud. The milestone reduces execution uncertainty and advances a potentially important long-term growth project. Centro Ambulatorio Trecca Conditions Precedent
  • Positive Sentiment: Auna’s analyst and investor day provided additional investor visibility into its strategy, operating trends and regional growth opportunities. Auna Analyst and Investor Day Transcript
  • Neutral Sentiment: Analysts cited a consensus price target of $6.97, implying potential upside from the recent trading level, although target prices are estimates rather than guarantees. Auna Consensus Target Price
  • Negative Sentiment: Auna lowered its 2026 EBITDA outlook because of contract-related pressure in Colombia. The reduction raises concerns about near-term profitability and margins even though revenue guidance was maintained. Auna Cuts 2026 EBITDA Outlook

About Auna

(Get Free Report)

Auna SA is a Latin American healthcare company that provides integrated medical services through a network of hospitals, clinics, outpatient centers and specialized care facilities. Its operations include hospital care, ambulatory services, diagnostic testing, oncology treatment, preventive care and other medical specialties.

The company also offers healthcare plans and programs designed to provide access to medical services, including specialized oncology coverage. Auna’s business model combines healthcare financing and service delivery, allowing it to serve patients across different stages of care, from prevention and diagnosis to treatment and follow-up.

Auna is headquartered in Peru and serves markets in Latin America, including Peru, Colombia and Mexico.

Recommended Stories

Analyst Recommendations for Auna (NYSE:AUNA)

Receive News & Ratings for Auna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Auna and related companies with MarketBeat.com's FREE daily email newsletter.